1. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Science, Rockville, Maryland 20857, 2000.
2. Particle design: a ‘Supercritical’ issue for the pharma industry;York;Pharm.Visions,2000
3. Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization;Morissette;Proc. Natl. Acad. Sci.,2003
4. Control of physical forms of pharmaceutical substances;Chow,2004
5. Theory and origin of polymorphism;Grant,1999